hydro research semaglutide GLP-1 Receptor Agonist Reference Hydro Research Semiglutide | TikTok

(2021) "Once-weekly semaglutide in adults with overweight or obesity" New England Journal of Medicine, 384(11) 2

Semaglutide is a Glucagon-like Peptide-1 Agonist that stimulates the GLP-1 receptors in our body

More importantly, NSAIDs can increase gastrointestinal irritation when added to semaglutide's existing digestive side effects, so acetaminophen may be the preferable fever and pain option during acute illness

Make checking expiration dates part of your routine before each injection or when taking oral medication

2-4 Weeks: Early Weight Loss By weeks 2-4, many patients begin to see measurable results: Initial weight loss often becomes noticeable on the scale Average weight loss ranges from 2-5 pounds during this phase Side effects, if any, typically stabilize Portion sizes naturally decrease as satiety signals improve This early period is when most patients start feeling encouraged by visible progress